mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 32 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 1,152,727 | 0 | T | G | 61.5% | 5.3 / 12.7 | 13 | G165G (GGT→GGG) | ycfH | metal‑dependent hydrolase |
| * | NZ_CP009273 | 807,177 | 0 | T | G | 59.1% | 22.5 / 26.2 | 22 | V67G (GTG→GGG) | bioC | malonyl‑ACP O‑methyltransferase BioC |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 58.5% | ‑1.1 / 43.6 | 41 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 822,955 | 0 | T | G | 58.3% | 3.7 / 10.4 | 12 | T495P (ACC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 1,024,812 | 0 | T | G | 58.3% | 3.8 / 12.4 | 12 | Y205S (TAC→TCC) | rlmI | 23S rRNA (cytosine(1962)‑C(5))‑methyltransferase RlmI |
| * | NZ_CP009273 | 765,675 | 0 | A | C | 57.9% | 15.0 / 18.0 | 19 | T748P (ACC→CCC) | mngB | mannosylglycerate hydrolase |
| * | NZ_CP009273 | 1,152,745 | 0 | A | G | 57.1% | 4.2 / 14.4 | 14 | G171G (GGA→GGG) | ycfH | metal‑dependent hydrolase |
| * | NZ_CP009273 | 4,213,525 | 0 | C | T | 57.1% | ‑3.4 / 12.3 | 14 | R11K (AGA→AAA) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
| * | NZ_CP009273 | 1,340,910 | 0 | C | A | 56.2% | 9.7 / 23.9 | 16 | L30F (TTG→TTT) | pdeR | cyclic di‑GMP phosphodiesterase |
| * | NZ_CP009273 | 2,089,567 | 0 | T | G | 56.2% | 9.7 / 17.3 | 16 | G81G (GGT→GGG) | hisF | imidazole glycerol phosphate synthase subunit HisF |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 56.1% | 10.9 / 46.4 | 41 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 2,794,496 | 0 | T | G | 53.8% | 7.3 / 12.8 | 13 | V58G (GTG→GGG) | nrdI | class Ib ribonucleoside‑diphosphate reductase assembly flavoprotein NrdI |
| * | NZ_CP009273 | 4,527,926 | 0 | A | C | 53.8% | 6.9 / 15.2 | 13 | G219G (GGT→GGG) | nanM | N‑acetylneuraminate epimerase |
| * | NZ_CP009273 | 510,074 | 0 | T | C | 53.3% | 15.6 / 20.2 | 15 | E81G (GAA→GGA) | ybbJ | NfeD family protein |
| * | NZ_CP009273 | 2,089,571 | 0 | A | G | 53.3% | 3.9 / 15.0 | 15 | I83V (ATT→GTT) | hisF | imidazole glycerol phosphate synthase subunit HisF |
| * | NZ_CP009273 | 2,193,661 | 0 | T | G | 53.3% | 14.8 / 16.7 | 15 | pseudogene (3709/3796 nt) | BW25113_RS25680 | WGR and DUF4132 domain‑containing protein |
| * | NZ_CP009273 | 3,941,210 | 0 | C | T | 53.3% | 3.8 / 18.1 | 15 | E40K (GAA→AAA) | hdfR | HTH‑type transcriptional regulator HdfR |
| * | NZ_CP009273 | 3,963,417 | 0 | A | C | 53.3% | 8.7 / 11.0 | 15 | T343P (ACC→CCC) | wzzE | ECA polysaccharide chain length modulation protein |
| * | NZ_CP009273 | 297,075 | 0 | A | C | 52.9% | 20.0 / 23.1 | 17 | V175G (GTG→GGG) | paoB | aldehyde oxidoreductase FAD‑binding subunit PaoB |
| * | NZ_CP009273 | 443,161 | 0 | T | A | 52.9% | 9.5 / 21.0 | 17 | M1M (ATG→TTG) † | cyoE | heme o synthase |
| Marginal new junction evidence (sorted from low to high skew) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP009273 | 454243 = | 24 (1.160) | 5 (0.250) | 5/160 | 1.4 | 17.8% | intergenic (+87/‑101) | clpX/lon | ATP‑dependent protease ATP‑binding subunit ClpX/endopeptidase La |
| ? | NZ_CP009273 | = 604803 | NA (NA) | intergenic (+170/+112) | BW25113_RS03025/entD | IS4‑like element IS421 family transposase/enterobactin synthase subunit EntD | |||||